Navigation Links
Vet-Stem and Central Veterinary Research Labs of Dubai Sign Exclusive License
Date:9/13/2007

SAN DIEGO, Sept. 13 /PRNewswire/ -- Vet-Stem, Inc., the global leader in regenerative veterinary medicine, has licensed their proprietary stem cell technology to the Central Veterinary Research Laboratory (CVRL) of Dubai in the United Arab Emirates. The license allows the laboratory to offer adipose- derived stem cell services to animal owners throughout the Middle East region. The ruler of Dubai and Prime Minister of the United Arab Emirates, Sheik Mohammed bin Rashid al-Maktoum, is one of the world's largest thoroughbred owners and sponsors the richest horse racing day, the Dubai World Cup. "The Central Veterinary Research Laboratory will be an excellent partner in bringing this technology from the US to the Middle East as they are already the most respected reference lab in the region," says Dr. Bob Harman, CEO of Vet-Stem. The CVRL intends to provide stem cell services for treatment of injuries in thoroughbred race horses, Arabian endurance horses, racing camels, and many other species. Vet-Stem's clients in the United States have already treated over 2500 horses and over 100 dogs with arthritis, tendon, and ligament injuries with a success rate of over 70% return to normal performance.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060425/VETSTEMLOGO)

Vet-Stem delivers stem and other regenerative cells from a small fat sample for use in treating an animal's own injuries. This clearly avoids the controversy of using stem cells taken from embryos. This technology provides the opportunity for regeneration and healing of tendon and ligament injuries instead of the normal scarring process which reduces performance and may increase chances of re-injury. Stem cells are delivered to the veterinarian only 48 hours after a small fat sample is collected from the injured animal. Priority overnight shipment has allowed Vet-Stem to develop veterinary clients in all parts of the country and has eliminated regional issues typically associated with service expansion. "Our success in animals is directly translatable to humans, said Robert J. Harman, DVM, MPVM CEO Vet-Stem, Inc., "and we wish to share our evidence that stem cells are safe and effective".

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals.

In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. Since that time there has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Studies have shown that mesenchymal stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.

For additional information, contact:

Vet-Stem, Inc.

Dr. Julie Ryan Johnson

12860 Danielson Court, Suite BPoway, CA 92064

858-748-2004

info@vet-stem.com


'/>"/>
SOURCE Vet-Stem, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Madison start-up Central Signal gets $350K grant
2. Will wireless Internet bypass the central city?
3. Norlight to expand fiber network into central Illinois
4. Centralization mania takes over
5. Meterologix Media Division acquired by Madison-based Weather Central
6. Weather Central launches second satellite
7. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
8. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
9. Control Your siRNA Research
10. Getting Started with MicroRNA Research
11. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... 23, 2016 ReportsnReports.com adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):